[1]
“Carcinogenic Impurities in Generic Sartans: An Issue of Authorities’ Control or a Problem with Generics?”, Rhythmos, vol. 14, no. 2, pp. 23–26, Apr. 2019, Accessed: May 03, 2025. [Online]. Available: https://www.rhythmos.gr/index.php/Rhythmos/article/view/455